INDICATION: Breast Cancer ...
BCIQ Company Profiles
Boston Children's Hospital
Harvard Medical School
Northeastern University
BCIQ Target Profiles
Intercellular adhesion molecule-1 (ICAM-1) (CD54)
Lipocalin 2 (LCN2) (NGAL)